▲ +73.08% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Sintx Technologies in the last 3 months. The average price target is $3.38, with a high forecast of $4.50 and a low forecast of $2.25. The average price target represents a 73.08% upside from the last price of $1.95.
The current consensus among 2 contributing investment analysts is to buy stock in Sintx Technologies.
Sintx Technologies, Inc., a biomaterial company, researches, develops, manufactures, and commercializes a range of medical implant products manufactured with silicon nitride in the United States, Europe, and South America. It offers ceramic based biomaterial solutions in various medical and industrial applications. The company provides spine implant products under the Valeo brand to surgeons and hospitals for use in cervical and thoracolumbar spine surgery. Sintx Technologies, Inc. markets and sells its products directly; and through direct sales organizations, distributors, as well as original equipment manufacturer and private label partnerships. The company was formerly known as Amedica Corporation and changed its name to Sintx Technologies, Inc. in October 2018. Sintx Technologies, Inc. was founded in 1996 and is headquartered in Salt Lake City, Utah.